Advances in Bioprinting to Model Immune-Mediated Skin Diseases

    November 2025 in “ Advanced Healthcare Materials
    Andrea Ulloa‐Fernández, Marica Marković, Julia Fernández‐Pérez, Georg Stary, Aleksandr Ovsianikov
    Studysummary This review explores advancements in bioprinting technologies for developing in vitro skin models that replicate immune-mediated skin diseases, highlighting their potential to reduce animal testing and enhance research and product testing capabilities in dermatology.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The document reviews recent advancements in bioprinting technologies for creating in vitro skin models to study immune-mediated skin diseases, such as psoriasis, atopic dermatitis, vitiligo, and alopecia areata. These models aim to replicate human skin's physiological and architectural features, incorporating immune components to better understand inflammatory responses. Techniques like Laser-Induced Forward Transfer (LIFT) and Digital Light Processing (DLP) enhance precision and scalability, allowing for the integration of vascularization and immune cells. Despite challenges in achieving full clinical translation, these bioprinted models offer promising alternatives to animal testing, aiding in drug discovery and therapeutic development for chronic, non-communicable inflammatory skin diseases.
    Discuss this study in the Community →

    Research cited in this study

    16 / 16 results